Roche and Genentech researchers plot $53M discovery quest aimed at sparking a 'Holy moly' pivot in neuro R&D
Roche and Genentech have committed $53 million to back a 10-year quest aimed at going back to the drawing board to use new technology and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
